Yüklüyor......
Current Chemotherapy and Potential New Targets in Uterine Leiomyosarcoma
A variety of chemotherapeutic agents have been used for treating recurrent or advanced stage uterine leiomyosarcoma (ULMS). The response rates of these current agents are disappointing, with partial response rates varying from 0% to 33%, and complete response rates varying from 0% to 8%. Recent stud...
Kaydedildi:
| Yayımlandı: | J Clin Med Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elmer Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4737027/ https://ncbi.nlm.nih.gov/pubmed/26858789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2419w |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|